Aims/hypothesis The P12A variant in the PPARG gene and the E23K polymorphism in KCNJ11 are both known to influence individual predisposition to type 2 diabetes. If the effect of these variants on insulin secretion and action were to extend to an influence on early growth (which is largely mediated by insulin), it would offer an explanation for observed associations between low birthweight and subsequent diabetes. Since previous studies of the effects of these variants on early growth have been limited and conflicting, we examined these associations in a large, well-characterised birth cohort. Methods The P12A and E23K variants were genotyped in (respectively) 5,652 and 5,632 individuals from the Northern Finland Birth Cohort of 1966 and we sought associations with early growth phenotypes.
Introduction
The well-replicated relationship between restricted early growth and subsequent adult metabolic disease is generally ascribed to the long-term effects of an adverse maternal environment mediated through metabolic programming [1] . However, a complementary explanation of such associations is provided by the hypothesis that early growth and adult metabolic disease share genetic determinants [1] . Support for this latter explanation comes from monogenic forms of diabetes (such as those due to mutations in the GCK gene) and reported associations between paternal metabolic disease and reduced offspring birthweight [2] . However, some twin studies argue against such a shared genetic basis for these traits [3] .
One way to test the extent to which common variants with pleiotropic effects impact on observed associations between early growth and adult disease is to establish whether or not variants influencing susceptibility to metabolic conditions such as type 2 diabetes also influence early growth phenotypes. Until the recent advent of genome-wide association scans, common variants showing robust associations with individual susceptibility to type 2 diabetes were limited to just three genes (PPARG, KCNJ11 and TCF7L2) [4] .
Data on the effects of these variants on early growth phenotypes are limited and conflicting. Although it is known that rarer, more severe mutations in KCNJ11, which cause neonatal diabetes, result in low birthweight [4] , the only study of the common type 2 diabetes-susceptibility variant E23K found no association with birthweight [5] . In the case of PPARG, Eriksson and colleagues found no association between the P12A variant and birthweight in individuals from the Helsinki Birth Cohort, but did report an interaction effect, whereby the association between the alanine allele and lower fasting insulin in adulthood was restricted to low birthweight individuals [6] . A recent study suggested that carriers of the alanine allele were more likely to have a lower birthweight due to shorter gestation and, indeed, a higher frequency of alanine carriers was observed in the pre-term group [7] . In contrast, the largest study to date, involving 1,930 women and child pairs, found no association between the P12A variant and indices of early growth [8] . Finally, a large-scale study, which found evidence for higher birthweight amongst infants carrying type 2 diabetes-susceptibility alleles at the TCF7L2 locus, attributed this to an indirect effect mediated by the effects of maternal genotype on glucose levels during the pregnancy [9] .
In the present study, we set out to perform a wellpowered analysis of the effects of the established type 2 diabetes-susceptibility variants, P12A and E23K (in PPARG and KCNJ11 respectively) on early growth phenotypes, using more than 5,000 individuals from the Northern Finland Birth Cohort of 1966. Genotyping Genotyping was performed by KBioscience (Hoddesdon, UK; http://www.kbioscience.co.uk) using
Taqman assays (Applied Biosciences, Warrington, UK). The P12A and E23K variants were successfully genotyped in 5,652 and 5,632 samples (respectively) with estimated error rates <0.5% for both (∼400 duplicate genotypes). Allele frequencies at both sites (P12, 83%; E23, 52.3%) were consistent with those previously reported in Finns; there were no departures from Hardy-Weinberg equilibrium (p=0.39 and 0.59 respectively).
Statistical analyses Statistical analyses were performed using SPSS (version 14; SPSS, Chicago, IL, USA). Linear regression was used to investigate potential associations between genotypes and phenotypes of interest (after transformation to normality, where appropriate). We excluded twins from all analyses. In addition, participants with non-fasted samples (n=229) and those on diabetes medication (n=30) were excluded from analyses of insulin and HOMA-IR. Early growth analyses were optionally adjusted for a suite of variables (Table 1) , which, within the Northern Finland Birth Cohort of 1966 sample, display univariate associations: we report only the additive model. For analyses seeking to replicate the specific findings of previous studies [6, 7] , we reproduce the genotypic and phenotypic stratifications reported in those studies.
Power calculations Assuming a power of 80%, an alphavalue of 0.05 and an additive model, this study would have the power to detect a per-allele difference of 8% (∼43 g for birthweight) or 6% (∼32 g for birthweight) of a standard deviation for P12A and E23K respectively. This power is similar to studies in this cohort of the glucokinase −30 G/A variant (8.5%, ∼46 g for birthweight) or TCF7L2 rs7903146 (7%, ∼38 g for birthweight) [9] . 
Results
The main findings with respect to the associations between the P12A and E23K variants and early growth phenotypes are shown in Table 1 . Neither variant was significantly associated with birthweight, birth length, ponderal index or head circumference at 1 year. In addition, no associations were observed after stratification for parity or sex (data not shown).
There was a nominally significant association between the E23 allele and placental weight (p=0.026 adjusted).
To test the previously reported interaction between P12A and birthweight [6] , we divided birthweight into the same categories as the original report. We observed the expected association between low birthweight and raised adult measures of fasting insulin (p=2.5×10 −5 ) and HOMA-IR (p=3.3×10 −5 ). However, in contrast to the previous report [6] , we found no evidence that the P12A genotype had any impact on either variable in low-birthweight individuals (Table 2) . Neither was the A allele found to associate with low birthweight due to short gestation (p=0.81) or with preterm birth itself (p=0.66) as previously reported (data not shown) [7] .
Discussion
In this, the largest and most comprehensive study to date of the relationship between these established type 2 diabetessusceptibility variants and early growth, we did not find any evidence of shared pleiotropic effects. Such a finding would be consistent with the largest studies previously performed at each variant [5, 8] .
What might underlie these discrepant findings? Extensive genotyping quality control and standardised phenotyping have minimised the risk of technical errors affecting our study. In addition, we have previously demonstrated that this sample is able to detect other well-established genotypephenotype correlations [9, 10] . Overall, the most likely conclusion is that these two variants have little or no effect on early growth phenotypes, a finding which would be consistent with the previous large-scale studies [5, 8] .
However, we acknowledge that in this, as in any association study, failure to detect associations may reflect inadequate power to detect small effects [9] . The present study, although large, is also limited by the fact that maternal DNA samples were not available. In principle, any direct effects of susceptibility alleles in the offspring that lead to reduced birthweight (for example through reduced fetal insulin secretion) may be (partly or completely) offset by an opposing effect on early growth mediated through the effects of the same variants on maternal glucose levels [9] .
A full exploration of such effects is restricted to data sets featuring both fetal and maternal DNA samples.
In summary, our study failed to detect any significant associations between the E23K and P12A variants and a range of early growth phenotypes. This provides important evidence that there is limited overlap between susceptibility to type 2 diabetes and influences on early growth phenotypes, arguing against the notion of shared genetic determinants of both [1] . The recent identification, using genome-wide association approaches, of a number of further type 2 diabetessusceptibility variants provides the opportunity for additional tests of this hypothesis.
